Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Spain Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20123
20134
20142
20153
20167
201712
20186
20193
20207
20214
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Hoffmann-La Roche7
MedSIR4
Merck Sharp & Dohme LLC4
AbbVie3
Pfizer3
AstraZeneca2
Cantargia AB2
SOLTI Breast Cancer Research Group2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms59
Carcinoma, Non-Small-Cell Lung20
Breast Neoplasms15
Neoplasms11
Ovarian Neoplasms11
Melanoma10
Colorectal Neoplasms9
Pancreatic Neoplasms9
Stomach Neoplasms8
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.